FDA Inspection
Respa Pharmaceuticals Inc.Respa Pharmaceuticals Inc. – FDA Inspection, Oct 4, 2012
Record Details
This FDA Inspection record concerns Respa Pharmaceuticals Inc., with an inspection on October 4, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Respa Pharmaceuticals Inc.
- Inspection Date
- October 4, 2012
- Product Type
- Drugs
View Company Profile
ID · 72083ff8-c4da-42a5-a9fc-9ac800c23b1c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 801001
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- Drug Field Exam
- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Respa Pharmaceuticals Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 4, 2011 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
Other documents for Respa Pharmaceuticals Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.